News

Deal Announcements

Itero Biopharmaceuticals Closes Series A Round

Thursday, June 12, 2008 5:58:00 AM PDT | VentureDeal Staff
Burlingame, California -- Biotechnology company Itero Biopharmaceuticals has secured $21 million in its series A funding round.

Itero is developing what it calls "a value-added follow-on" and novel therapeutic proteins and antibodies.

The round was co-led by SV Life Sciences and Panorama Capital.  The new capital will be used to fund the initial development of the companies therapeutic candidate pipeline.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1